Tandem Diabetes Care (TNDM) PT Lowered to $22 at CFRA, 'we anticipate a $10 million headwind in 2025'
Tweet Send to a Friend
CFRA analyst Kenneth Leon lowered the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $22.00 (from $33.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
